{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:16:22Z","timestamp":1788430582408,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Henan Province Medical Science and Technique Foundation","award":["SBGJ202102097"],"award-info":[{"award-number":["SBGJ202102097"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study is a retrospective analysis of the prenatal genetic diagnosis results of 1408 foetuses at high risk of DMD\/BMD to provide information for clinical genetic counselling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Duchenne muscular dystrophy (DMD) is a severe neuromuscular disorder characterized by skeletal and cardiac muscle weakness. With the deepening of disease research, some treatments have been applied in clinics. Therefore, early and accurate prenatal diagnosis can inform pregnancy choices for high-risk families.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 1316 unrelated DMD\/BMD families with confirmed genetic diagnoses were recruited from the Genetic and Prenatal Diagnosis Center of the First Affiliated Hospital of Zhengzhou University. Prenatal diagnosis of 1408 high-risk foetuses was performed by MLPA and Sanger sequencing combined with STR linkage analysis for all families.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 1316 families, large deletions, duplications, and small variants of the\n                      <jats:italic>DMD<\/jats:italic>\n                      gene accounted for 70.4% (927\/1316), 8.2% (108\/1316), and 21.4% (281\/1316), respectively. Among 1316 mothers, 863 (65.6%) were carriers, and 453 (34.4%) were not carriers. The rate of\n                      <jats:italic>de novo<\/jats:italic>\n                      variants was 34.4% (453\/1316) in our study. In addition, gonadal mosaicism was observed in 11 pregnant females. Prenatal diagnosis was provided for 1408 high-risk foetuses; 282 foetuses were identified as male patients, 219 foetuses were female carriers, and the remainder had normal genetics. The results of prenatal diagnosis were consistent with the results of follow-up.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Accurate and rapid prenatal diagnosis can be achieved using MLPA, Sanger sequencing, and STR linkage analysis. Furthermore, germline mosaicism in DMD should not be ignored; considering this, a prenatal diagnosis for all pregnant women with a family history of DMD\/BMD regardless of whether they carried disease-causing variants is proposed. Genetic counselling and targeted prenatal diagnosis will continue to be a cornerstone of DMD\/BMD family management in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12920-023-01746-x","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T05:02:48Z","timestamp":1701406968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prenatal diagnosis of 1408 foetuses at risk of DMD\/BMD by MLPA and Sanger sequencing combined with STR linkage analysis"],"prefix":"10.1186","volume":"16","author":[{"given":"Chunxiao","family":"Hua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"1746_CR1","doi-asserted-by":"crossref","unstructured":"Landfeldt E, Thompson R, Sejersen T et al. Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis. Eur J Epidemiol, 2020, 35(3).","DOI":"10.1007\/s10654-020-00613-8"},{"issue":"1","key":"1746_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13023-014-0220-7","volume":"10","author":"X Li","year":"2015","unstructured":"Li X, Zhao L, Zhou S, et al. A comprehensive database of Duchenne and Becker muscular dystrophy patients (0\u201318 years old) in East China. Orphanet J Rare Dis. 2015;10(1):5.","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"1746_CR3","doi-asserted-by":"publisher","first-page":"e862","DOI":"10.1002\/mgg3.862","volume":"7","author":"J Park","year":"2019","unstructured":"Park J, Jang W, Han JY. Differing Disease phenotypes of Duchenne muscular dystrophy and Moyamoya Disease in female siblings of a Korean family. Mol Genet Genomic Med. 2019;7(9):e862.","journal-title":"Mol Genet Genomic Med"},{"issue":"3","key":"1746_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1590\/0004-282x20190168","volume":"78","author":"THD Silva","year":"2020","unstructured":"Silva THD, Anequini IP, Fvero FM, et al. Functional performance and muscular strength in symptomatic female carriers of Duchenne muscular dystrophy. Arq Neuropsiquiatr. 2020;78(3):143\u20138.","journal-title":"Arq Neuropsiquiatr"},{"key":"1746_CR5","unstructured":"National Institute of Neurological Disorders and Stroke (NINDS). Muscular Dystrophy Information. Accessed October 12., 2022. ninds.nih.gov\/Disorders\/All-Disorders\/Muscular-Dystrophy-Information-Page."},{"issue":"3","key":"1746_CR6","first-page":"172","volume":"38","author":"C Angelini","year":"2019","unstructured":"Angelini C, Marozzo R, Pegoraro V. Current and emerging therapies in Becker muscular dystrophy (BMD). Acta Myol. 2019;38(3):172\u20139.","journal-title":"Acta Myol"},{"key":"1746_CR7","doi-asserted-by":"publisher","first-page":"175675","DOI":"10.1016\/j.ejphar.2023.175675","volume":"947","author":"G Patterson","year":"2023","unstructured":"Patterson G, Conner H, Groneman M, et al. Duchenne muscular dystrophy: current treatment and emerging exon skipping and gene therapy approach. Eur J Pharmacol. 2023;947:175675.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1746_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17(3):251\u201367.","journal-title":"Lancet Neurol"},{"issue":"2","key":"1746_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/13543784.2021.1868434","volume":"30","author":"O Sheikh","year":"2021","unstructured":"Sheikh O, Yokota T, Developing. DMD therapeutics: a review of the effectiveness of small molecules, stop-codon readthrough, dystrophin gene replacement, and exon-skipping therapies. Expert Opin Investig Drugs. 2021;30(2):167\u201376.","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"1746_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/BF03260074","volume":"9","author":"V Ferreiro","year":"2005","unstructured":"Ferreiro V, Giliberto F, Francipane L, et al. The role of polymorphic short tandem (CA)n repeat loci segregation analysis in the detection of Duchenne muscular dystrophy carriers and prenatal diagnosis. Mol Diagn. 2005;9(2):67\u201380.","journal-title":"Mol Diagn"},{"issue":"10","key":"1746_CR11","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1001\/jamaneurol.2022.2480","volume":"79","author":"M Guglieri","year":"2022","unstructured":"Guglieri M, Clemens PR, Perlman SJ, et al. Efficacy and safety of Vamorolone vs Placebo and Prednisone among boys with Duchenne muscular dystrophy: a Randomized Clinical Trial. JAMA Neurol. 2022;79(10):1005\u201314.","journal-title":"JAMA Neurol"},{"issue":"2","key":"1746_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ana.24555","volume":"79","author":"JR Mendell","year":"2016","unstructured":"Mendell JR, Goemans N, Lowes LP, et al. Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy. Ann Neurol. 2016;79(2):257\u201371.","journal-title":"Ann Neurol"},{"issue":"1","key":"1746_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1089\/nat.2021.0043","volume":"32","author":"L Servais","year":"2022","unstructured":"Servais L, Mercuri E, Straub V, et al. Long-term safety and efficacy data of golodirsen in ambulatory patients with duchenne muscular dystrophy amenable to exon 53 skipping: a first-in-human, multicenter, two-part, open-label, phase 1\/2 trial. Nucleic Acid Ther. 2022;32(1):29\u201339.","journal-title":"Nucleic Acid Ther"},{"issue":"4","key":"1746_CR14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3233\/JND-220811","volume":"9","author":"PR Clemens","year":"2022","unstructured":"Clemens PR, Rao VK, Connolly AM, et al. Long-term functional efficacy and safety of Viltolarsen in patients with Duchenne muscular dystrophy. J Neuromuscul Dis. 2022;9(4):493\u2013501.","journal-title":"J Neuromuscul Dis"},{"issue":"12","key":"1746_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1358\/dot.2021.57.12.3352740","volume":"57","author":"H Wilton-Clark","year":"2021","unstructured":"Wilton-Clark H, Yokota T. Casimersen for Duchenne muscular dystrophy. Drugs Today (Barc). 2021;57(12):707\u201317.","journal-title":"Drugs Today (Barc)"},{"issue":"3","key":"1746_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2217\/cer-2021-0196","volume":"11","author":"CM McDonald","year":"2022","unstructured":"McDonald CM, Muntoni F, Penematsa V, et al. Ataluren delays loss of ambulation and respiratory decline in nonsense mutation duchenne muscular dystrophy patients. J Comp Eff Res. 2022;11(3):139\u201355.","journal-title":"J Comp Eff Res"},{"issue":"3","key":"1746_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S1525-1578(10)60560-0","volume":"7","author":"TW Prior","year":"2005","unstructured":"Prior TW, Bridgeman SJ. Experience and strategy for the molecular testing of Duchenne muscular dystrophy. J Mol Diagn. 2005;7(3):317\u201326.","journal-title":"J Mol Diagn"},{"issue":"10","key":"1746_CR18","doi-asserted-by":"publisher","first-page":"18168","DOI":"10.3390\/molecules201018168","volume":"20","author":"MS Falzarano","year":"2015","unstructured":"Falzarano MS, Scotton C, Passarelli C, et al. Duchenne muscular dystrophy: from diagnosis to Therapy. Molecules. 2015;20(10):18168\u201384.","journal-title":"Molecules"},{"issue":"1","key":"1746_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/0888-7543(88)90113-9","volume":"2","author":"AP Monaco","year":"1988","unstructured":"Monaco AP, Bertelson CJ, Liechti-Gallati S, et al. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 1988;2(1):90\u20135.","journal-title":"Genomics"},{"issue":"7","key":"1746_CR20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00439-019-02036-2","volume":"138","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Deng H, Chen X, et al. Skipping of an exon with a nonsense mutation in the DMD gene is induced by the conversion of a splicing enhancer to a splicing silencer. Hum Genet. 2019;138(7):771\u201385.","journal-title":"Hum Genet"},{"issue":"2","key":"1746_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00439-019-02107-4","volume":"139","author":"M Okubo","year":"2020","unstructured":"Okubo M, Noguchi S, Hayashi S, et al. Exon skipping induced by nonsense\/frameshift mutations in DMD gene results in Becker muscular dystrophy. Hum Genet. 2020;139(2):247\u201355.","journal-title":"Hum Genet"},{"issue":"12","key":"1746_CR22","doi-asserted-by":"publisher","first-page":"e05166","DOI":"10.1002\/ccr3.5166","volume":"9","author":"W Liu","year":"2021","unstructured":"Liu W, Shi X, Li Y, et al. The identification of a novel splicing mutation in the DMD gene of a Chinese family. Clin Case Rep. 2021;9(12):e05166.","journal-title":"Clin Case Rep"},{"issue":"4","key":"1746_CR23","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/pd.5019","volume":"37","author":"H Wang","year":"2017","unstructured":"Wang H, Xu Y, Liu X, et al. Prenatal diagnosis of Duchenne muscular dystrophy in 131 Chinese families with dystrophinopathy. Prenat Diagn. 2017;37(4):356\u201364.","journal-title":"Prenat Diagn"},{"issue":"4","key":"1746_CR24","first-page":"429","volume":"25","author":"AB Luna-Angulo","year":"2014","unstructured":"Luna-Angulo AB, Gomez-Diaz B, Escobar-Cedillo RE, et al. A new de novo mutation in a non-hot spot region at the DMD gene in a Mexican family. Genet Couns. 2014;25(4):429\u201332.","journal-title":"Genet Couns"},{"issue":"1","key":"1746_CR25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12881-020-01157-0","volume":"21","author":"Y Wang","year":"2020","unstructured":"Wang Y, Chen Y, Wang SM, et al. Prenatal diagnosis of Duchenne muscular dystrophy revealed a novel mosaic mutation in Dystrophin gene: a case report. BMC Med Genet. 2020;21(1):222.","journal-title":"BMC Med Genet"},{"issue":"3","key":"1746_CR26","first-page":"179","volume":"31","author":"T Grimm","year":"2012","unstructured":"Grimm T, Kress W, Meng G, et al. Risk assessment and genetic counseling in families with Duchenne muscular dystrophy. Acta Myol. 2012;31(3):179\u201383.","journal-title":"Acta Myol"},{"issue":"9","key":"1746_CR27","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41431-020-0643-7","volume":"28","author":"C Fratter","year":"2020","unstructured":"Fratter C, Dalgleish R, Allen SK, et al. EMQN best practice guidelines for genetic testing in dystrophinopathies. Eur J Hum Genet. 2020;28(9):1141\u201359.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"1746_CR28","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.tjog.2013.10.014","volume":"52","author":"MH Ta","year":"2013","unstructured":"Ta MH, Tran TH, Do NH, et al. Rapid method for targeted prenatal diagnosis of Duchenne muscular dystrophy in Vietnam. Taiwan J Obstet Gynecol. 2013;52(4):534\u20139.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"1","key":"1746_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12920-021-01128-1","volume":"14","author":"G Zhao","year":"2021","unstructured":"Zhao G, Wang X, Liu L, et al. Noninvasive prenatal diagnosis of duchenne muscular dystrophy in five Chinese families based on relative mutation dosage approach. BMC Med Genomics. 2021;14(1):275.","journal-title":"BMC Med Genomics"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01746-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-023-01746-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01746-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T05:05:58Z","timestamp":1701407158000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-023-01746-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1746"],"URL":"https:\/\/doi.org\/10.1186\/s12920-023-01746-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2538759\/v1","asserted-by":"object"}]},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]},"assertion":[{"value":"1 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the First Affiliated Hospital of Zhengzhou University Committee, Zhengzhou, China (2020-KY-0393-002). Informed consent was obtained from patients at the time of genetic sample collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"310"}}